| abstract |
A 4-pyridone (4-pyridinone) derivative of Formula I and pharmaceutically acceptable salts thereof, crystalline forms of said 4-pyridone derivative and salts thereof, pharmaceutical compositions comprising such 4-pyridone derivative and salts thereof and the use of the pharmaceutical compostitions in the chemotherapy of certain parasitic infections such as malaria, and in particular infection by Plasmodium falciparum. |